Parasitic diseases in travelers: a focus on therapy

被引:8
作者
Showler, Adrienne J. [1 ]
Wilson, Mary E. [2 ]
Kain, Kevin C. [1 ,3 ,4 ]
Boggild, Andrea K. [1 ,3 ,5 ]
机构
[1] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada
[2] Global Hlth & Populat Harvard Sch Publ Hlth, Boston, MA USA
[3] UHN Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada
[4] Univ Toronto, Rotman Ctr Global Hlth, Sandra A Rotman Labs, Toronto, ON, Canada
[5] Publ Hlth Ontario, Publ Hlth Ontario Labs, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
diarrhea; protozoa; pharmacology; travel; fever; helminthes; eosinophilia; skin lesions; rash; parasites; WORLD CUTANEOUS LEISHMANIASIS; PLASMODIUM-FALCIPARUM-MALARIA; INTRALESIONAL MEGLUMINE ANTIMONIATE; TRANSMITTED HELMINTH INFECTIONS; RANDOMIZED CLINICAL-TRIAL; LIPOSOMAL AMPHOTERICIN-B; PLACEBO-CONTROLLED TRIAL; AMEBIC LIVER-ABSCESS; REAL-TIME PCR; DOUBLE-BLIND;
D O I
10.1586/14787210.2014.892827
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Parasitic infections are an important cause of illness among returned travelers, and can lead to considerable morbidity and, in some cases, mortality. The complexity of parasitic life cycles and geographic specificities can present diagnostic challenges, particularly in non-endemic settings to which most travelers return for care. Clinical manifestations reflect the diverse taxonomy and pathogenesis of parasites, and appropriate diagnosis and management therefore necessitate a high index of suspicion of parasitic illnesses. Much of our knowledge surrounding management of parasitic infections in travelers is extrapolated from evidence derived in endemic populations, or is based on expert opinion and case series. We herein provide an overview of parasitic diseases of short-term travelers, and summarize current therapeutic strategies for each illness.
引用
收藏
页码:497 / 521
页数:25
相关论文
共 194 条
[1]  
Abba K, 2010, COCHRANE DATABASE SY
[2]  
Adams VJ, 2004, SAMJ S AFR MED J, V94, P972
[3]   Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites [J].
Ali, Vahab ;
Nozaki, Tomoyoshi .
CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (01) :164-+
[4]   Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major [J].
Alrajhi, AA ;
Ibrahim, EA ;
De Vol, EB ;
Khairat, M ;
Faris, RM ;
Maguire, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :891-895
[5]   Short Report: Can We Use a Lower Dose of Liposomal Amphotericin B for the Treatment of Mucosal American Leishmaniasis? [J].
Amato, Valdir S. ;
Tuon, Felipe F. ;
Camargo, Raphael A. ;
Souza, Regina M. ;
Santos, Carolina R. ;
Nicodemo, Antonio C. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 85 (05) :818-819
[6]   Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis [J].
Andersen, EM ;
Cruz-Saldarriaga, M ;
Llanos-Cuentas, A ;
Luz-Cjuno, M ;
Echevarria, J ;
Miranda-Verastegui, C ;
Colina, O ;
Berman, JD .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (02) :133-137
[7]  
[Anonymous], 2013, OXAB SCYX 7158
[8]  
[Anonymous], 2013, FEX HAT
[9]   Plant active components - a resource for antiparasitic agents? [J].
Anthony, JP ;
Fyfe, L ;
Smith, H .
TRENDS IN PARASITOLOGY, 2005, 21 (10) :462-468
[10]   Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years [J].
Antinori, Spinello ;
Schifanella, Luca ;
Million, Matthieu ;
Galimberti, Laura ;
Ferraris, Laurenzia ;
Mandia, Luca ;
Trabucchi, Giuseppe ;
Cacioppo, Viviana ;
Monaco, Gaspare ;
Tosoni, Antonella ;
Brouqui, Philippe ;
Gismondo, Maria Rita ;
Giuliani, Giuseppe ;
Corbellino, Mario .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (09) :E649-E662